A detailed history of Captrust Financial Advisors transactions in Biogen Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 6,494 shares of BIIB stock, worth $967,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,494
Previous 7,309 11.15%
Holding current value
$967,735
Previous $1.69 Million 25.74%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $154,092 - $192,992
-815 Reduced 11.15%
6,494 $1.26 Million
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $31,435 - $39,058
-165 Reduced 2.21%
7,309 $1.69 Million
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $569,485 - $719,069
-2,686 Reduced 26.44%
7,474 $1.61 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $38,730 - $46,621
-174 Reduced 1.68%
10,160 $2.63 Million
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $191,748 - $216,418
-757 Reduced 6.83%
10,334 $2.66 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $698,584 - $807,236
2,538 Added 29.67%
11,091 $3.16 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $59,778 - $68,115
-233 Reduced 2.65%
8,553 $2.38 Million
Q4 2022

Feb 15, 2023

BUY
$252.44 - $306.72 $259,508 - $315,308
1,028 Added 13.25%
8,786 $2.43 Million
Q3 2022

Nov 16, 2022

BUY
$194.69 - $268.46 $126,548 - $174,499
650 Added 9.14%
7,758 $2.07 Million
Q2 2022

Aug 23, 2022

BUY
$187.54 - $223.02 $1.28 Million - $1.52 Million
6,808 Added 2269.33%
7,108 $1.45 Million
Q2 2022

Aug 16, 2022

SELL
$187.54 - $223.02 $1.04 Million - $1.23 Million
-5,527 Reduced 94.85%
300 $61,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $167,804 - $211,425
-866 Reduced 12.94%
5,827 $1.23 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $21,048 - $27,050
94 Added 1.42%
6,693 $1.61 Million
Q3 2021

Nov 16, 2021

BUY
$282.99 - $369.05 $157,625 - $205,560
557 Added 9.22%
6,599 $1.87 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $33,670 - $53,912
-130 Reduced 2.11%
6,042 $2.09 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $245,136 - $287,191
1,009 Added 19.54%
6,172 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $78,910 - $118,780
334 Added 6.92%
5,163 $1.26 Million
Q3 2020

Nov 17, 2020

SELL
$264.77 - $305.71 $84,726 - $97,827
-320 Reduced 6.21%
4,829 $1.38 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $270,558 - $358,307
1,046 Added 25.49%
5,149 $1.36 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $45,166 - $57,294
-168 Reduced 3.93%
4,103 $1.2 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $653,798 - $903,391
2,971 Added 228.54%
4,271 $1.26 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $4,566 - $5,121
21 Added 1.64%
1,300 $303,000
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $23,244 - $25,622
-106 Reduced 7.65%
1,279 $299,000
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $89,717 - $140,329
-414 Reduced 23.01%
1,385 $327,000
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $42,889 - $54,323
154 Added 9.36%
1,799 $541,000
Q3 2018

Nov 15, 2018

BUY
$293.51 - $383.83 $378,921 - $495,524
1,291 Added 364.69%
1,645 $581,000
Q2 2018

Aug 13, 2018

SELL
$257.52 - $306.91 $59,229 - $70,589
-230 Reduced 39.38%
354 $103,000
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $59,569 - $84,251
229 Added 64.51%
584 $156,000
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $103,059 - $115,434
335 Added 1675.0%
355 $113,000
Q3 2017

Feb 16, 2018

BUY
$281.15 - $329.69 $5,623 - $6,593
20
20 $6,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.